John Maraganore bought $249K of Rapport Therapeutics stock
By AlphaYouPublished Form 4
MARAGANORE JOHN
Reporting filer
John Maraganore reported buying 9,411 shares of Rapport Therapeutics, Inc. for about $249K ($26.45 a share on average). Form 4 filed Oct 22, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Oct 22, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | MARAGANORE JOHN | 2026-10-22 | P | Purchase | 8239 | 26.3799 | 8,239 | 0 days | Filed terms
|
| Common Stock | MARAGANORE JOHN | 2026-10-22 | P | Purchase | 1172 | 26.9173 | 9,411 | 0 days | Filed terms
|
Common Stock
- Owner
- MARAGANORE JOHN
- Date
- 2026-10-22
- Code
- P
- Action
- Purchase
- Quantity
- 8239
- Price
- 26.3799
- Following holdings
- 8,239
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-22
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 8239
- transaction Price Per Share: 26.3799
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 8239
- direct Or Indirect Ownership: I
- nature Of Ownership: By John M. Maraganore Revocable Trust
Common Stock
- Owner
- MARAGANORE JOHN
- Date
- 2026-10-22
- Code
- P
- Action
- Purchase
- Quantity
- 1172
- Price
- 26.9173
- Following holdings
- 9,411
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-22
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: false
- transaction Shares: 1172
- transaction Price Per Share: 26.9173
- id: F2
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 9411
- direct Or Indirect Ownership: I
- nature Of Ownership: By John M. Maraganore Revocable Trust
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- MARAGANORE JOHN: Director.
- F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.81 to $26.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
- F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.81 to $26.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Original sources
Prepared automatically from public filing data. Report a correction.